Key senate panel considers medicare bonuses for hospitals that prevent drug shortages

feature-image

Play all audios:

Loading...

WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that take measures to prevent drug shortages. It also wants to change the way doctors are paid to


administer drugs in outpatient settings. After a startling number of drugs, including chemotherapies, were in shortage last year, Washington stepped up its efforts to find policy solutions


for the problems. Most experts say the way that Medicare pays hospitals and doctors, along with the dominance of group purchasing organizations that buy hospital drugs, together force


generic drugmakers to cut prices for cheaper generics so low that there is no money left for maintaining facilities or using reliable, diversified supply chains. The result is that


facilities get shut down or generic drug manufacturers exit markets, leaving too few makers of drugs to supply demand. STAT+ Exclusive Story Already have an account? Log in THIS ARTICLE IS


EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS ARTICLE — PLUS DAILY INTELLIGENCE ON CAPITOL HILL AND THE LIFE SCIENCES INDUSTRY — BY SUBSCRIBING TO STAT+. Already have an account? Log in


Individual plans Group plans View All Plans To read the rest of this story subscribe to STAT+. Subscribe